Navigation Links
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Date:11/23/2009

MALVERN, Pa. and FRAZER, Pa., Nov. 23 /PRNewswire-FirstCall/ -- Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. (Nasdaq: CEPH) today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms. Analyses of the data indicated that patients treated with CINQUIL showed a statistically significant reduction in esophageal eosinophil levels versus placebo. In the second co-primary endpoint, patients treated with CINQUIL showed an improvement in their clinical symptoms; however, placebo treated patients also experienced an unexpectedly large improvement in their symptoms. Therefore, the study did not achieve statistical significance for this endpoint. CINQUIL was well tolerated in the study, with an adverse event profile comparable to placebo. Ception and Cephalon continue to fully analyze the data and are planning to perform an analysis of an ongoing open-label extension study to help further assess the clinical results.

"We are pleased to see a positive biological effect of CINQUIL," said Steve Tullman, Chief Executive Officer at Ception Therapeutics. "Conducting clinical studies in a new disease area is always challenging. We will continue to review the data from this study and from our ongoing open-label study to find the best path forward for CINQUIL for the treatment of eosinophilic esophagitis."

The four-month, double-blind, placebo-controlled clinical trial evaluated the efficacy and safety of CINQUIL in 226 pediatric patients between five and 18 years of age with poorly controlled EoE. Study participants were randomized to receive one of t
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009
2. Hologic to Host Investor Reception at RSNA 2009
3. Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin
4. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
5. Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma
6. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
7. Huge Drop in Preterm Birth-Risk Among Women Taking Folic Acid One Year Before Conception
8. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
9. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
10. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
11. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 The European ... defines and segments the concerned market in Europe ... non-invasive & minimally invasive cardiac output monitoring devices market in ... in 2014 and is estimated to grow to $89.8 million ... 2019. Browse through the TOC of European non-invasive ...
(Date:3/2/2015)... 2, 2015 Cure SMA recently announced a new ... Research (CALIBR). This funding is an extension of a spinal ... $700,000 Cure SMA grant to Dr. Peter G. Schultz ... of Small Molecules that Increase SMN2 Levels for ... neuron (SMN) protein is critical to the function of the ...
(Date:3/2/2015)... GLENWOOD, Ill. , March 2, 2015  Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... today announced it will release financial results for the ... Monday, March 9, 2015. The Company ... Tuesday, March 10, 2015 at 9:00 a.m. Central Time ...
Breaking Medicine Technology:European Non-Invasive & Minimally Invasive Cardiac Output Monitoring Devices Market is Expected to Reach $89.8 Million by 2019, at a CAGR of 4.2% from 2014 to 2019 2European Non-Invasive & Minimally Invasive Cardiac Output Monitoring Devices Market is Expected to Reach $89.8 Million by 2019, at a CAGR of 4.2% from 2014 to 2019 3Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2
... Genprex, Inc. announced today that it will be presenting at ... San Francisco.   Greg Heinlein , Chief Operating and Financial Officer, ... Forum , on October 25 starting at 11 a.m. PDT in ... be made available on the company,s website under the News & ...
... CINCINNATI, Oct. 20, 2011 Prasco Laboratories , announced ... Eli Lilly and Company (NYSE: LLY ... Tablets and ZYPREXA® ZYDIS (olanzapine) Orally Disintegrating Tablets, in the ... products upon the first ANDA entrant into the market.  Prasco ...
Cached Medicine Technology:Genprex Presenting at 10th Annual BIO Investor Forum 2Prasco® Selected as Eli Lilly and Company's Authorized Generics Partner 2
(Date:3/3/2015)... March 03, 2015 The Data 360 ... at the Ford Conference Center, Dearborn, MI, on March 5, ... Inc., is a featured speaker. He is known internationally as ... , These designations were earned due to years of ... commercially-available NoSQL DB, released over 10 years ago. Subsequent developments ...
(Date:3/3/2015)... 03, 2015 Sponsors of Medicare Advantage ... abundance of significant proposed changes to sift through as ... 2016 Call Letter released Feb. 20. The potential pay ... vary considerably with the type and location of the ... and comment on them before CMS issues the final ...
(Date:3/3/2015)... March 03, 2015 When a lifeguard is on ... Comfort is more than just loose clothing. For a ... to the public too much when the guard prefers to cover ... morning or the evening and wearing the clothing that fits correctly. ... during a shift, it is imperative that the guard stays warm ...
(Date:3/3/2015)... HealthCarePoint (HCP) , the Texas-based ... that it has completed development of the BlueCloud™ ... Consortium (CDISC). HCP will continue to provide in-kind ... and certifications globally. HCP’s in-kind services will also ... well as development of dynamic identification for country-specific ...
(Date:3/3/2015)... Omaha, NE (PRWEB) March 03, 2015 ... healthcare staffing, including Physician jobs, has announced that it ... Fair to be held Tuesday, March 17, 2015 in ... with an opportunity to meet job-seeking residents and fellows ... Medical’s physician division will be available to ...
Breaking Medicine News(10 mins):Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:March 12 Webinar to Analyze Implications of CMS’s ’45-Day Notice’ and 2016 Call Letter for MA and Part D Plans 2Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 2Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 3Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 4Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 3
... who take commonly prescribed drugs for osteoporosis known as bisphosphonates ... of certain kinds of fractures of their thigh bone, a ... hip fractures. And, since the overall risk of thigh bone ... risk for hip and other osteoporosis-related fractures should not stop ...
... Huggins HealthDay Reporter , TUESDAY, Feb. 22 (HealthDay ... looks good on a resume when you,re young, it may ... A new study finds that seniors who speak three, four ... memory than their peers. Most people already know the ...
... February 22, 2011 (BRONX, NY) In an ... at Albert Einstein College of Medicine of ... improve survival after life-threatening blood loss. Nanoparticles containing nitric ... where they helped maintain blood circulation and protect vital ...
... Feb. 22, 2011 Getting more exercise, spending time ... can be as effective as drugs or counseling in ... anxiety, according to a UC Irvine study. In ... human behavior, philosophy and anthropology, as well as adjunct ...
... Reporter , TUESDAY, Feb. 22 (HealthDay News) -- Men and ... of ischemic stroke, which typically occurs when blood flow to ... within blood vessels, a new Danish study contends. In ... triglyceride fats than it is for cholesterol, even though cholesterol ...
... LANSING, Mich. Want to keep your boss happy? Smile ... Smile like you mean it. A new study led ... who fake smile throughout the day worsen their mood and ... a result of cultivating positive thoughts such as a ...
Cached Medicine News:Health News:Study links long-term use of osteoporosis drugs to unusual fractures 2Health News:Speaking Several Languages Might Protect Memory 2Health News:Speaking Several Languages Might Protect Memory 3Health News:Nanoparticles increase survival after blood loss 2Health News:Therapeutic lifestyle changes as useful as drugs in improving mental health 2Health News:High Triglyceride Levels Linked to Increased Stroke Risk: Study 2Health News:High Triglyceride Levels Linked to Increased Stroke Risk: Study 3Health News:Study: For a better workday, smile like you mean it 2
ROC XS is a polyethylene implant used for soft tissue reattachment to bone. The umbrella-like deployment of this anchor provides increased fixation strength. This anchor is easy-to-insert using the R...
... The Rotator Cuff Anchor (RCA), ... for soft tissue reattachment to bone. ... which eliminates the need to predrill ... in fixation is due to subcortical ...
... The Linvatec 5mm Super Revo Suture ... for arthroscopic or a mini-open rotator cuff ... and the anchor is pre-threaded with two ... potential pitfalls of suture management are avoided ...
... the standard measurement procedure to ... operations in just one step. ... Start button, the R-F10 automatically ... steps for both eyes: alignment, ...
Medicine Products: